Finance

Lists
Why is CAMLINFINE down 3.80%?
Dive Deeper
CAMLINFINE:NSE
Camlin Fine Sciences Ltd
₹76.88
-3.80%
(-3.04) 1D
Nov 13, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for CAMLINFINE...
Open
₹79.74
High
₹79.74
Low
₹76.50
Mkt. cap
14.74B
Avg. vol.
863.77K
Volume
453.80K
P/E ratio
271.37
52-wk high
₹192.00
52-wk low
₹73.25
EPS
₹0.28
Shares outstanding
121.25M
No. of employees
674
Open
₹79.74
High
₹79.74
Low
₹76.50
Mkt. cap
14.74B
Avg. vol.
863.77K
Volume
453.80K
P/E ratio
271.37
52-wk high
₹192.00
52-wk low
₹73.25
EPS
₹0.28
Shares outstanding
121.25M
No. of employees
674
News stories
From web sources and news partners
Profile
Camlin Fine Sciences originated as part of the Camlin group, an Indian manufacturer of stationery and art materials. The company subsequently expanded into the specialty chemicals sector, focusing on antioxidant ingredients and related chemical products. During the 2000s and 2010s, the company expanded its international operations through acquisitions and investments in overseas manufacturing facilities. These activities increased the company's presence in Europe and Latin America and broadened its product portfolio. In 2015, Camlin Fine Sciences acquired a controlling interest in Dresen Química, a Brazilian manufacturer of food preservation and shelf-life extension products, expanding its operations in South America. The company later entered the aroma chemicals and vanillin production sectors through investments in manufacturing facilities and related businesses. Company manufactures chemicals to improve the shelf life of food and other products like aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone and Butylated hydroxyanisole. It is also one of the world's leading Vanillin producers. Wikipedia
About Camlin Fine Sciences Ltd
CEO-
Employees674
Founded1931
Headquarters-
SectorMaterials
IndustrySpeciality chemicals
Last report
Nov 3, 2026
Fiscal period
Q2 2027
-₹1.29 / -₹0.40
-221.48%miss
Revenue / Est. (INR)
4.91B / 5.31B
-7.46%miss
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.57B
3.83B
5.20B
4.91B
Cost of goods sold
2.48B
2.24B
3.06B
2.96B
Cost of revenue
2.48B
2.24B
3.06B
2.96B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
637.64M
886.99M
734.29M
722.66M
Operating expense
2.04B
1.52B
2.16B
2.13B
Total operating expenses
4.52B
3.76B
5.21B
5.09B
Operating income
53.04M
65.46M
-15.12M
-176.86M
Other non operating income
29.36M
-94.79M
13.40M
49.56M
EBT including unusual items
-278.54M
2.25M
-322.59M
-348.87M
EBT excluding unusual items
-103.43M
94.48M
-211.49M
-329.61M
Income tax expense
452.00K
-64.02M
-4.63M
-68.06M
Effective tax rate
-0.16%
-2,849.31%
1.44%
19.51%
Other operating expenses
1.23B
449.93M
1.23B
1.21B
Net income
-362.30M
882.02M
-317.06M
-278.54M
Net profit margin
-7.92%
23.05%
-6.10%
-5.67%
Earnings per share
-0.94
0.76
-0.99
-1.29
Interest and investment income
-
79.64M
-
-
Interest expense
-183.29M
-76.78M
-162.78M
-205.92M
Net interest expenses
-183.29M
2.86M
-162.78M
-205.92M
Depreciation and amortization charges
167.28M
184.44M
191.56M
199.19M
EBITDA
203.20M
199.10M
118.52M
18.52M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps